CHINA TOPIX

11/22/2024 02:15:59 am

Make CT Your Homepage

Multiple Myeloma

FDA Approves Kyprolis As A Second-Line Treatment For Multiple Myeloma

FDA Approves Kyprolis As A Second-Line Treatment For Multiple Myeloma

Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone is approved by FDA for use in patients ailing from relapsed multiple myeloma that has received two to three prior therapies including treatment with bortezomib (Velcade, Millennium).

Vaccine

Measles Virus Used To Kill Woman's Cancer

A woman suffering from an advanced form of blood cancer was declared free of the disease after being injected with a massive dose of the measles vaccine.

Real Time Analytics